Stock listing

NASDAQ:ACGN Aceragen Inc. Stock

Follow Aceragen Inc. into a list and get an email when it puts out news.

Delisted NASDAQ:ACGN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ACGN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Jan 7, 2014 – Jun 23, 2022 · Past
Carol A. Schafer
Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Repare Therapeutics Inc (Director · Since at least May 13, 2021); Insmed Incorporated (Director · Since at least May 12, 2021); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past)
Director · Oct 1, 2020 – Jun 23, 2022 · Past
James Geraghty
Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Jul 17, 2019); Voyager Therapeutics, Inc. (Director · Since at least Jun 15, 2016); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Palvella Therapeutics, Inc. (Director · May 22, 2017 – Dec 12, 2024 · Past); Juniper Pharmaceuticals Inc (Director · Aug 2, 2016 – Aug 14, 2018 · Past)
Director · May 13, 2016 – Jun 23, 2022 · Past
Vincent Milano
Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jul 26, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jan 7, 2020); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Viropharma Inc (President and CEO, Director · Jun 7, 2010 – Jan 24, 2014 · Past); Vanda Pharmaceuticals Inc. (Director · Apr 21, 2010 – Jun 13, 2018 · Past)
Director · Dec 1, 2014 – Aug 10, 2023 · Past
John Peter Wolf III
Other companies: Nabriva Therapeutics AG (General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past); Viropharma Inc (VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past)
General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past
Carl N Kraus
Other companies: Aquestive Therapeutics, Inc. (Chief Medical Officer · Since at least Jun 26, 2023)
CHIEF MEDICAL OFFICER · Sep 28, 2022 – Jan 20, 2023 · Past
Daniel Salain
Other companies: CalciMedica, Inc. (CTOO · Sep 24, 2020 – Dec 8, 2020 · Past)
CHIEF OPERATING OFFICER · Sep 28, 2022 – Jan 20, 2023 · Past
Louis J Arcudi III
Other companies: Tempest Therapeutics, Inc. (President and CEO, Director · Dec 7, 2018 – Feb 26, 2021 · Past)
Chief Financial Officer · Jan 3, 2017 – Aug 13, 2018 · Past
John Clayton TaylorCHIEF EXECUTIVE OFFICER, Director · Sep 28, 2022 – Jan 20, 2023 · Past
Jonathan Michael YinglingChief Scientific Officer · Jul 9, 2019 – Jan 10, 2020 · Past
All 12 people
PersonSeat
Robert C FletcherSr. VP, Bus. Dev. & Strategy · Jan 3, 2017 – Jul 21, 2020 · Past
Sudhir AgrawalPresident of Research, Director · Jan 6, 2016 – Jan 3, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Aceragen Inc.